Status:
UNKNOWN
Evaluating Clinical Parameters of COVID-19 in Pregnancy
Lead Sponsor:
Chelsea and Westminster NHS Foundation Trust
Conditions:
COVID-19
2019 Novel Coronavirus Infection
Eligibility:
All Genders
18-60 years
Brief Summary
Coronavirus infection, also known as COVID-19, has become a global pandemic with over 3 million cases and 250,000 deaths worldwide. Coronaviruses (CoV) belong to a family of viruses that predominately...
Detailed Description
This study will be a retrospective case review using existing clinical data from participating centres. To date there have already been 18,000 confirmed cases in Greater London. Our study design will ...
Eligibility Criteria
Inclusion
- COVID-19 infection
- 18-50 years for Groups A and B and 18-60 years for Groups C and D
- Female for groups A and B. Both male and female for groups C and D.
Exclusion
- Participants who have previously been part of a SARS-CoV-2 vaccine trial.
- Current hospital admission due to another respiratory disease, such as influenza.
- Obvious clinical deterioration due to another medical problem such as cardiovascular disease, diabetes or malignancy.
- Evidence of HIV infection and/or participants on anti-retroviral drug therapy.
- Participants on chemotherapy, biologics, immune-modulators or immunosuppressive drugs (not including intramuscular steroids for fetal lung maturity).
Key Trial Info
Start Date :
October 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 2 2021
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04470583
Start Date
October 9 2020
End Date
December 2 2021
Last Update
October 12 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom, SW10 9NH
2
Chelsea and Westminster Hospital
London, United Kingdom, SW10 9NH